Back to Search
JOHN PALMER, MD
Hematology & Oncology Physician
NPI: 1982109898IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD61634924(WA)
Education
OTHER
Class of 2018
Research & Publications (20)
C-peptide in the natural history of type 1 diabetes.
PMID 19267337·Diabetes Metab Res Rev·2009
6-review
Using a filtering task to measure the spatial extent of selective attention.
PMID 18405935·Vision Res·2009
8-other
Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?
PMID 16306342·Diabetes·2005
6-review
The effect of stimulus strength on the speed and accuracy of a perceptual decision.
PMID 16097871·J Vis·2005
8-other
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
PMID 14693724·Diabetes·2004
8-other
Beta cell rest and recovery--does it bring patients with latent autoimmune diabetes in adults to euglycemia?
PMID 12021087·Ann N Y Acad Sci·2002
6-review
Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.
PMID 11435453·J Clin Invest·2001
4-observational
The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary.
PMID 18317224·Int J Gynecol Pathol·2008
8-other
Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.
PMID 18983204·J Manag Care Pharm·2008
8-other
Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary.
PMID 17885489·Int J Gynecol Pathol·2007
8-other
Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.
PMID 16644215·Bioorg Med Chem Lett·2006
7-preclinical
Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.
PMID 16546382·Bioorg Med Chem Lett·2006
7-preclinical
Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.
PMID 16302794·J Med Chem·2005
7-preclinical
Control of brittleness in butyl-methylmethacrylate resin embedding mixtures to facilitate their use in immunofluorescence microscopy.
PMID 11318510·Cytobios·2001
8-other
Awake tracheal intubation with the intubating laryngeal mask in a patient with diffuse idiopathic skeletal hyperostosis.
PMID 10594434·Anaesthesia·2000
5-case
Novel mechanism of rapamycin in GVHD: increase in interstitial regulatory T cells.
PMID 19597415·Bone Marrow Transplant·2010
7-preclinical
Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation/prevascularization tissue engineering model.
PMID 19650726·Tissue Eng Part A·2010
7-preclinical
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
PMID 19503110·Bone Marrow Transplant·2010
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1560 N 115TH ST STE G16
SEATTLE, WA 98133 - Phone
- (206) 606-5800
Quick Facts
- NPI
- 1982109898
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile